Race-free Chronic Kidney Disease Epidemiology Collaboration equation
| Stage | eGFR (mL/min/1.73m²) | Description | Drug Dosing Impact |
|---|---|---|---|
| G1 | ≥ 90 | Normal or high | Standard dosing |
| G2 | 60–89 | Mildly decreased | Monitor; minimal dose adjustment |
| G3a | 45–59 | Mild-moderately decreased | Adjust renally-cleared drugs |
| G3b | 30–44 | Moderate-severely decreased | Reduce doses; avoid nephrotoxins |
| G4 | 15–29 | Severely decreased | Significant reductions; prepare for RRT |
| G5 | < 15 | Kidney failure | Dialysis doses; many drugs contraindicated |